Key result
In-hospital mortality was lower for HFpEF patients with high blood pressure at admission compared to those without, with different prognostic factors identified for each group.
Why the study?
Does in-hospital treatment with beta-blockers or diuretics reduce in-hospital mortality in HFpEF patients with versus without high blood pressure?
Cohort (n=2,238)
Yes
Does in-hospital treatment with beta-blockers or diuretics reduce in-hospital mortality in HFpEF patients with versus without high blood pressure?
Answers are grounded in this paper and cite their sources.
Beta-blockers may be beneficial for HFpEF patients presenting with high blood pressure, whereas diuretics may be more beneficial for those without high blood pressure, suggesting a role for phenotype-guided therapy.
OBJECTIVE: No agents have been proven to improve survival in heart failure with preserved ejection fraction (HFpEF), but the phenotypic diversity of HFpEF suggests it may be possible to identify specific HFpEF phenotypes that will benefit from certain treatments. This study compared the risk factors for and prognostic impacts of treatments on in-hospital mortality between HFpEF patients with (+) and without (-) high blood pressure (HBP). METHODS: Data on 2238 consecutive HFpEF patients were extracted from Tokyo CCU Network data registry and analysed. HFpEF was defined as an ejection fraction greater than or equal to 50%; HBP was defined as elevated systolic blood pressure (>140 mmHg) at admission. Potential risk factors for in-hospital mortality were selected by univariate analyses and those with P < 0.10 were used in multivariate Cox regression analysis with forward selection (likelihood ratio) to identify significant factors. RESULTS: In-hospital mortality was significantly lower for HFpEF + HBP than HFpEF - HBP patients (log-rank, P < 0.001). Independent risk factors for in-hospital mortality in HFpEF + HBP patients were older age (hazard ratio 1.069) and in-hospital treatment without beta-blockers (hazard ratio 7.946), whereas older age (hazard ratio 1.035), higher C-reactive protein (hazard ratio 1.047), higher B-type natriuretic peptide (hazard ratio 1.000) and in-hospital treatment without diuretics (hazard ratio 4.201) were identified as independent risk factors in HFpEF - HBP patients. CONCLUSION: There were significant differences in prognostic factors, including beta-blocker and diuretic treatments, for in-hospital mortality between HFpEF patients with and without HBP. These findings suggest possible individualized therapies for patients with HFpEF.
No takes yet. Share an insight, caveat, or question.
Matsushita et al. (2018) conducted a cohort in Heart failure with preserved ejection fraction (HFpEF) (n=2,238). High blood pressure (HBP) at admission (>140 mmHg) vs. Without high blood pressure (≤140 mmHg) was evaluated on In-hospital mortality (p=<0.001). In-hospital mortality was lower for HFpEF patients with high blood pressure at admission compared to those without, with different prognostic factors identified for each group.
Synapse has enriched 10 related papers. Consider them for comparative context: